Artwork

Conteúdo fornecido por Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !

The Heart of the Matter: Behind the Renewed Interest in Cardiovascular Disease

24:43
 
Compartilhar
 

Manage episode 379625853 series 2991382
Conteúdo fornecido por Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

A conversation on the rising trends in the cardiology space

Cardiology has historically been a cornerstone of large pharmaceutical portfolios. The late 2000s and 2010s saw many pharmaceutical companies and investors abandon or severely deprioritize cardiology research and development in favor of oncology, immunology, and neurology.

During this episode of The Life Science Report, Dr. Pete Bak and Christian Thienel of Back Bay Life Science Advisors discuss the major players in the industry and novel approaches to future cardiology applications.

Episode topics include:

  • Why pharma’s interest in specialty-like approaches has shifted towards cardiology
  • The promise of “advanced modalities” and gene therapies, such as antisense oligonucleotides (ASOs) and small interfering RNA (siRNA)
  • How these newer treatments stack up against traditional small molecule orals, like statins
  • Clinical stage pipeline analysis across cardiology and visible trends on the horizon

This is the 20th episode of Back Bay’s podcast, covering all facets of healthcare development and transactions. For questions, be in touch: www.bblsa.com

  continue reading

28 episódios

Artwork
iconCompartilhar
 
Manage episode 379625853 series 2991382
Conteúdo fornecido por Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Back Bay Life Science Advisors, Jonathan P. Gertler, and Peter Bak ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.

A conversation on the rising trends in the cardiology space

Cardiology has historically been a cornerstone of large pharmaceutical portfolios. The late 2000s and 2010s saw many pharmaceutical companies and investors abandon or severely deprioritize cardiology research and development in favor of oncology, immunology, and neurology.

During this episode of The Life Science Report, Dr. Pete Bak and Christian Thienel of Back Bay Life Science Advisors discuss the major players in the industry and novel approaches to future cardiology applications.

Episode topics include:

  • Why pharma’s interest in specialty-like approaches has shifted towards cardiology
  • The promise of “advanced modalities” and gene therapies, such as antisense oligonucleotides (ASOs) and small interfering RNA (siRNA)
  • How these newer treatments stack up against traditional small molecule orals, like statins
  • Clinical stage pipeline analysis across cardiology and visible trends on the horizon

This is the 20th episode of Back Bay’s podcast, covering all facets of healthcare development and transactions. For questions, be in touch: www.bblsa.com

  continue reading

28 episódios

Tutti gli episodi

×
 
Loading …

Bem vindo ao Player FM!

O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.

 

Guia rápido de referências